← Back to headlines
Eli Lilly's Taltz-Zepbound Combo Shows Breakthrough in Psoriasis-Obesity Trial
Eli Lilly has announced a landmark trial demonstrating a major breakthrough with its Taltz-Zepbound drug combination for treating both psoriasis and obesity.
21 Feb, 17:31 — 21 Feb, 17:31
ℹOnly 1 source covers this story
Read at source (1 outlet)
Related Stories
Friends Launch GoFundMe for Eric Dane's Daughters After Actor's ALS Death
12m ago
Running — the one exercise that midlife women really need to do - The Times
1h ago
Study Links Hidden Gut Virus to Increased Colorectal Cancer Risk
1h ago
Running — the one exercise that midlife women really need to do - The Times
3h ago